|
|
| | MDM2-IN-26 Basic information |
| Product Name: | MDM2-IN-26 | | Synonyms: | MDM2-IN-26;Bicyclo[2.2.2]octane-1-carboxylic acid, 4-[[[(3′R,4′S,5′R)-6′′-chloro-4′-(3-chloro-2-fluorophenyl)-4,4-difluoro-1′′,2′′-dihydro-2′′-oxodispiro[cyclohexane-1,2′-pyrrolidine-3′,3′′-[3H]indol]-5′-yl]carbonyl]amino]- | | CAS: | 1818393-11-1 | | MF: | C32H32Cl2F3N3O4 | | MW: | 650.52 | | EINECS: | | | Product Categories: | | | Mol File: | 1818393-11-1.mol |  |
| | MDM2-IN-26 Chemical Properties |
| Boiling point | 813.796±65.00 °C(Press: 760.00 Torr)(predicted) | | density | 1.515±0.10 g/cm3(Temp: 25 °C; Press: 760 Torr)(predicted) | | pka | 4.761±0.10(predicted) |
| | MDM2-IN-26 Usage And Synthesis |
| Uses | MDM2-IN-26 (compound A3) is an MDM2 inhibitor that can activate the tumor suppressor function of p53 by blocking the interaction between MDM2 and p53 (MDM2 is the main negative regulator of p53). MDM2-IN-26 can be used for cancer research[1]. | | References | [1] Yifan Zhai, et al. MDM2 inhibitor and a platinum compound for cancer treatment. Patent US11850239B2. |
| | MDM2-IN-26 Preparation Products And Raw materials |
|